Alcon (ALC) EPS (Diluted) Growth (3y) (2021 - 2026)
Powered by 
Analysis
Alcon (ALC) EPS (Diluted) Growth (3y) (2021 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Diluted) Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 178.01 Bn | 172.41 Bn | 7.27 Bn | -12.16% |
| 2 | Intuitive Surgical | 131.29 Bn | 126.08 Bn | 1.96 Bn | 24.56% |
| 3 | Medtronic | 116.38 Bn | 107.56 Bn | 6.34 Bn | 24.50% |
| 4 | Stryker | 106.01 Bn | 102.53 Bn | 4.50 Bn | 19.81% |
| 5 | Boston Scientific | 63.40 Bn | 62.86 Bn | 3.85 Bn | 50.83% |
| 6 | Edwards Lifesciences | 48.89 Bn | 44.64 Bn | 1.35 Bn | -6.12% |
| 7 | Alcon | 32.59 Bn | 31.13 Bn | 1.68 Bn | - |
| 8 | Dexcom | 31.84 Bn | 29.89 Bn | 830.00 Mn | 33.46% |
| 9 | Steris | 20.61 Bn | 20.13 Bn | 684.20 Mn | 18.07% |
| 10 | Zimmer Biomet Holdings | 18.00 Bn | 17.59 Bn | 1.54 Bn | 1.16% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2026 | 17.95% |
| Dec 31, 2025 | 121.55% |
| Sep 30, 2025 | 29.97% |
| Jun 30, 2025 | 6.13% |
| Dec 31, 2024 | 35.54% |
| Sep 30, 2024 | 117.21% |
| Jun 30, 2024 | -1.67% |
| Mar 31, 2024 | 41.69% |
| Dec 31, 2023 | -26.50% |
| Sep 30, 2023 | 50.68% |
| Jun 30, 2023 | 34.55% |
| Mar 31, 2023 | 71.82% |
| Dec 31, 2022 | -77.31% |
| Sep 30, 2022 | 69.16% |
| Jun 30, 2022 | -9.98% |
| Mar 31, 2022 | 134.72% |
| Dec 31, 2021 | 50.38% |
| Sep 30, 2021 | 50.24% |
| Jun 30, 2021 | 91.19% |
| Mar 31, 2021 | 16.78% |